| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |